Solventum Corporation

NYSE:SOLV

Medical - Care Facilities

Healthcare
$86.48 -2.61%

-$2.00 today

Market cap
$14.70B
Beta
0.75
P/E (TTM)
9.1
EPS (TTM)
$8.22
52W Low $62.38High $88.20

Volume 0.76M

Average 1.70M

SOLV Purchases of Investments

Cash used to buy marketable securities and other investments.

Solventum CorporationNYSE: SOLV

Purchases of Investments · Q2 FY2026 · quarter ended Jun 2026

Purchases of investments outflow grows to $0

Q2 FY2026 purchases of investments was $0, compared with $0 a year earlier. Trailing-twelve-month purchases of investments was $0.

Context

  • Purchases of investments amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
  • Purchases of investments increased in 0 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly purchases of investments holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterJun 2026
$0— QoQ
Last fiscal yearDec 2025
$0— YoY
LTMJun 2026
$0— YoY
Purchases of Investments past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Purchases of Investments history

USD · from the cash flow

Latest · FY2025
0 USD
Year-over-year change
—

Purchases of Investments vs competitors

How SOLV compares with its peers on the latest reported figures

  • SOLV's LTM Jun 2026 purchases of investments of $0 is the 2nd largest of the 10 companies compared; the peer median is $0.
  • Purchases of investments amounts to 0.0% of revenue for SOLV, versus a peer median of 0.0%.
SOLV Competitors Peer median
Purchases of Investments for SOLV and competitors
Company Period LTM YoY 3-year CAGR% of revenue
NVSTEnvista Holdings CorpLTM Oct 2026$12.6M +28.6%—0.4%
SOLVSolventum CorporationLTM Jun 2026$0 ——0.0%
BDXBecton, Dickinson and CompanyLTM Sep 2026$0 +100.0%—0.0%
BAXBaxter International Inc.LTM Jun 2026$0 ——0.0%
COOThe Cooper Companies, Inc.LTM Jul 2026$0 ——0.0%
HSICHenry Schein, Inc.LTM Jun 2026$0 ——0.0%
MMSIMerit Medical Systems, Inc.LTM Sep 2026$0 ——0.0%
ICUIICU Medical, Inc.LTM Jun 2026$0 ——0.0%
XRAYDENTSPLY SIRONA Inc.LTM Mar 2026$0 +100.0%—0.0%
UTMDUtah Medical Products, Inc.LTM Mar 2026$0 ——0.0%
Peer median (excluding SOLV) $0+100.0%—0.0%

Competitors are the stored peer set for SOLV. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income1.46B1.34B1.35B479M1.56B
Depreciation & Amortization597M578M561M555M489M
Deferred Income Tax(34M)(141M)(142M)(155M)(120M)
Stock-Based Compensation38M37M39M112M161M
Change in Working Capital67M(202M)126M160M(119M)
Accounts Receivables(1M)(32M)(129M)276M78M
Inventory(136M)(82M)23M(132M)(139M)
Accounts Payables68M25M105M266M104M
Other Working Capital136M(113M)127M(250M)(162M)
Other Non-Cash Items74M64M(15M)34M(1.6B)
Operating Cash Flow2.2B1.68B1.92B1.19B369M
Capital Expenditures(277M)(251M)(290M)(380M)(379M)
Acquisitions (Net)0060M0(696M)
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities(1M)(2M)003.87B
Investing Cash Flow(278M)(253M)(230M)(380M)2.8B
Debt Repayment0008B(3.07B)
Common Stock Issued00000
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities(1.96B)(1.46B)(1.55B)(8.24B)13M
Financing Cash Flow(1.96B)(1.46B)(1.55B)(240M)(3.06B)
Effect of Forex Changes3M4M03M7M
Net Change in Cash(33M)(30M)133M568M116M
Free Cash Flow1.93B1.43B1.63B805M(10M)

Solventum Corporation

NYSE:SOLV

Intrinsic Alpha fair value

Locked

Current Price

$86.48

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.